Return to list

Henan Province Vice Governor Lü Guofan visited Zhongjie Pharmaceutical for a special research visit, providing guidance on safe drug production and high-quality industrial development.

2025-12-19

  On December 16, Lu Guofan, Vice Governor of Henan Province, and his delegation visited Henan Zhongjie Pharmaceutical Co., Ltd. to conduct a special research study and provide on-site guidance on drug safety production and industrial development. Chairman Ma Keguang and other colleagues from the company accompanied the delegation and reported on relevant matters. 

       As one of the first pharmaceutical enterprises in Henan Province to obtain national GMP certification, Zhongjie Pharmaceutical has grown into a modern pharmaceutical company integrating research and development, production, and sales. The company has established 13 state-of-the-art production lines that meet GMP standards, creating a distinctive product portfolio that combines traditional Chinese medicine with Western medicine, with a focus on cardiovascular and cerebrovascular products, anti-tumor drugs, and anti-rheumatic medications. Its product line covers eight dosage forms and ten therapeutic categories, holding 64 drug approval numbers, 58 patents for independent intellectual property rights, and 32 registered trademarks. With a diversified production capacity—including an annual output of 7 billion tablets, 1.5 billion capsules, and 500 million sachets—Zhongjie Pharmaceutical has laid a solid foundation for ensuring public access to essential medicines and promoting the healthy development of the pharmaceutical industry. 

         During the research, Vice Governor Lü Guofan first visited the company’s intelligent operations and dispatch center in depth and listened carefully to a briefing on the real-time monitoring system for production data and logistics information. This intelligent operations hub, which received an investment of 100 million yuan and has a total construction area of 9,600 square meters, deeply integrates core technology platforms such as SCADA, WMS, and AGV. It enables real-time monitoring, intelligent analysis, and precise control of production equipment and public facilities, driving a digital and intensive transformation across the entire production and warehousing process. As a result, the company’s production capacity and operational efficiency have increased by 1.5 times, fully demonstrating the remarkable achievements of Zhongjie Pharmaceutical’s digital transformation. 
         Subsequently, Vice Governor Lü Guofan visited the production floor to conduct an on-site inspection of the pharmaceutical manufacturing processes and the comprehensive quality-control system throughout the entire production chain. He praised Zhongjie Pharmaceutical’s steadfast commitment to upholding the bottom line of quality and safety. He highly commended Zhongjie Pharmaceutical’s remarkable achievements in intelligent transformation, emphasizing that drug safety is a red line that directly concerns people’s lives and health. Enterprises must earnestly fulfill their principal responsibilities and continuously strengthen quality control across the entire production process. At the same time, they should seize the opportunities presented by digital transformation, increase investment in scientific and technological innovation, break through technological bottlenecks, enhance their core competitiveness, and contribute further to the high-quality development of Henan’s pharmaceutical industry and the construction of a Healthy Central China. 
        Chairman Mark Guang expressed his heartfelt gratitude for the guidance and care provided by the company’s leadership. At the same time, Zhongjie Pharmaceutical is committed to firmly implementing the spirit of these instructions, continuously improving its quality management system to meet even higher standards, accelerating the integration of industry, academia, and research, and speeding up the commercialization of scientific and technological achievements. We will comprehensively promote the upgrading of production toward intelligence and green practices, earnestly fulfill our social responsibilities, and keep making sustained efforts in ensuring drug safety, driving industrial innovation, and serving the health of the people, thereby making new and greater contributions to regional economic development and the well-being of the public.

Real-time news